| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 21,160,000 | 16,532,000 | 14,842,000 | 16,673,000 | | Cost of Revenue | 19,293,000 | 16,171,000 | 14,193,000 | 15,461,000 | | | Gross Profit | 1,867,000 | 361,000 | 649,000 | 1,212,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 381,000 | 366,000 | 346,000 | 337,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,486,000 | (5,000) | 303,000 | 875,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 90,000 | 78,000 | (22,000) | | Earnings Before Interest And Taxes | 1,486,000 | 150,000 | 245,000 | 946,000 | | Interest Expense |
-
| 88,000 | 93,000 | 120,000 | | Income Before Tax | 1,486,000 | 62,000 | 152,000 | 826,000 | | Income Tax Expense | 440,000 | (2,000) | 144,000 | 241,000 | | Minority Interest | (1,000) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,045,000 | 64,000 | 8,000 | 585,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,045,000 | 64,000 | 8,000 | 585,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,045,000 | $64,000 | $8,000 | $585,000 |
|
0.01% Nasdaq 0.00%
Income Statement
